Number of CD34⁺ cells.

(A) Number of CD34⁺ cells in peripheral blood of progressors and LTNPs (n = 7 for each group) more than 1 year before (black bars) and 2 years after (white bars) seroconversion. (B) Number of CD34⁺ or CD34⁺/CD7⁺ cells in bone marrow (BM) or peripheral blood mononuclear cells (PBMC) of 4 participants in the Era trial before therapy (black bars) and after 6 months of therapy (white bars). P values were determined using the Wilcoxon signed-rank test.